Document Detail


Adjuvant therapy and long-term management of differentiated thyroid carcinoma.
MedLine Citation:
PMID:  9890737     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
As with most therapies for differentiated thyroid carcinoma, there is little consensus about optimal use of postoperative adjuvant therapies or long-term follow-up strategies. However, an increasing body of data indicates that most patients can benefit from postoperative radioiodine ablation followed by thyroid hormone suppression therapy. An approach to long-term monitoring and therapy is provided, including the use of strategies dependent upon the extent of the patient's initial disease.
Authors:
S I Sherman
Related Documents :
3600277 - Urinary excretion of 3-methylhistidine and creatinine and plasma concentrations of amin...
17274057 - Cyclooxygenase-2 expression in medullary thyroid carcinoma.
12678507 - Hypocalcemia and hypoparathyroidism after total thyroidectomy: a clinical biological st...
7235947 - The morbidity of total thyroidectomy.
19119927 - Role of hyperbaric oxygen therapy in the treatment of bacterial spinal osteomyelitis.
9698967 - An unusual toxic reaction to axillary block by mepivacaine with adrenaline.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Seminars in surgical oncology     Volume:  16     ISSN:  8756-0437     ISO Abbreviation:  Semin Surg Oncol     Publication Date:    1999 Jan-Feb
Date Detail:
Created Date:  1999-03-11     Completed Date:  1999-03-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8503713     Medline TA:  Semin Surg Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  30-3     Citation Subset:  IM    
Affiliation:
Section of Endocrine Neoplasia and Hormonal Disorders, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA. sisherma@mdanderson.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antithyroid Agents / therapeutic use
Carcinoma / radiotherapy,  surgery,  therapy*
Humans
Radiotherapy, Adjuvant
Thyroid Neoplasms / radiotherapy,  surgery,  therapy*
Chemical
Reg. No./Substance:
0/Antithyroid Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surgical management of laryngotracheal and esophageal involvement by locally advanced thyroid cancer...
Next Document:  Management of the patient with progressive radioiodine non-responsive disease.